Trial intelligence / Profile preview

DC071 Mouthwash for Alveolar Osteitis Prevention

NCT02382809Phase 4Completed

Sponsor
Pierre Fabre Laboratories
Start
Mar 2015
Primary completion
Feb 2016
Modality
Small Molecules
Countries
4
01

Overview

A Phase 4 trial of chlorhexidine in alveolar osteitis (AO), sponsored by Pierre Fabre Laboratories. Started Mar 2015; status: completed.

02

Drugs

chlorhexidine
03

Conditions

alveolar osteitis (AO)

Beyond the preview

Go deeper on NCT02382809.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02382809.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call